BABA

Alibaba Group Holding Limited

53
Fundamentals36/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential23/ 100

BABA has the edge over HNST overall, supported by lower modeled downside.

HNST

The Honest Company, Inc.

49
Fundamentals45/ 100
Valuation50/ 100
Upside potential61/ 100
Risk potential35/ 100

HNST offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

BABA Fundamentals

MetricStatus
Stable
Under pressure
Weak
Healthy

BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.

HNST Fundamentals

MetricStatus
Under pressure
Stable
Strong
Strong

HNST's cash flow and balance sheet are currently strong, and its profitability is stable, but its revenue is under pressure.

BABA PE Valuation

CHEAPFAIREXPENSIVE9.3x19x28x37x
CHEAPFAIREXPENSIVE9.3x19x28x37x
LevelPEPriceVs current
Cheap16x$69.66-26%
Fair20x$86.59-8.2%
Current21x$94.36—
Expensive26x$115+22%

Historical ranges are pointers, not guarantees.

BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.

HNST PE Valuation

CHEAPFAIREXPENSIVE21x43x64x85x
CHEAPFAIREXPENSIVE21x43x64x85x
LevelPEPriceVs current
Current7x$4.80—
Cheap41x$28.21+488%
Fair45x$31.17+549%
Forward60x$4.80—
Expensive78x$53.97+1024%

Historical ranges are pointers, not guarantees.

HNST has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.

BABA Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
Low

BABA has the edge over HNST on the outlook, with more favorable revenue expectations.

HNST Forward outlook

MetricOutlook
Strongly deteriorating
Strong growth
Stable
Strongly improving
Limited
Low

Analysts expect HNST's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.

BABA Risk to reward

ScenarioChangePrice
Upside+33%$125.09
Downside-23%$72.35

Calculated from the latest close: $94.36 on Nov 12.

BABA trails HNST on modeled risk to reward, with less potential upside relative to its potential downside.

HNST Risk to reward

ScenarioChangePrice
Upside+56%$7.48
Downside-35%$3.10

Calculated from the latest close: $4.80 on Nov 12.

HNST has a better modeled risk to reward balance than BABA, with more potential upside relative to its potential downside.

BABA Earnings Per Share

Q3 2023: $8.12Q4 2023: $6.04Q1 2024: $4.71Q2 2024: $4.29Q3 2024: $5.26Q4 2024: $7.47Q1 2025: $8.06Q2 2025: $9.27Q3 2025: $7.85Q4 2025: $5.79Q1 2026: $6.57Q2 2026: $4.42
Q3 2023: $8.12Q4 2023: $6.04Q1 2024: $4.71Q2 2024: $4.29Q3 2024: $5.26Q4 2024: $7.47Q1 2025: $8.06Q2 2025: $9.27Q3 2025: $7.85Q4 2025: $5.79Q1 2026: $6.57Q2 2026: $4.42
QuarterTTM EPSYoY
Q2 2026$4.42-52%
Q1 2026$6.57-18%
Q4 2025$5.79-22%
Q3 2025$7.85+49%
Q2 2025$9.27+116%
Q1 2025$8.06+71%
Q4 2024$7.47+24%
Q3 2024$5.26-35%

BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.

HNST Earnings Per Share

Q4 2023: $-0.42Q1 2024: $-0.23Q2 2024: $-0.13Q3 2024: $-0.04Q4 2024: $-0.06Q1 2025: $-0.02Q2 2025: $0.05Q3 2025: $0.06Q4 2025: $-0.14Q1 2026: $-0.17Q2 2026: $-0.11Q3 2026: $0.69Forward: $0.08
Q4 2023: $-0.42Q1 2024: $-0.23Q2 2024: $-0.13Q3 2024: $-0.04Q4 2024: $-0.06Q1 2025: $-0.02Q2 2025: $0.05Q3 2025: $0.06Q4 2025: $-0.14Q1 2026: $-0.17Q2 2026: $-0.11Q3 2026: $0.69Forward: $0.08
QuarterTTM EPSYoY
Forward$0.08-88%
Q3 2026$0.69+1050%
Q2 2026-$0.11-320%
Q1 2026-$0.17-$0.15
Q4 2025-$0.14-$0.08
Q3 2025$0.06+$0.10
Q2 2025$0.05+$0.18
Q1 2025-$0.02+$0.21
Q4 2024-$0.06+$0.36

HNST has the edge over BABA on earnings, with more consistent year-over-year improvement.

BABA Quarterly Revenue

Q3 2023: $33.7BQ4 2023: $39.1BQ1 2024: $33.3BQ2 2024: $36.5BQ3 2024: $35.5BQ4 2024: $42BQ1 2025: $35.5BQ2 2025: $37.2BQ3 2025: $37.2BQ4 2025: $42.7BQ1 2026: $36.5BQ2 2026: $40.2B
Q3 2023: $33.7BQ4 2023: $39.1BQ1 2024: $33.3BQ2 2024: $36.5BQ3 2024: $35.5BQ4 2024: $42BQ1 2025: $35.5BQ2 2025: $37.2BQ3 2025: $37.2BQ4 2025: $42.7BQ1 2026: $36.5BQ2 2026: $40.2B
QuarterRevenueYoY
Q2 2026$40.2B+8.3%
Q1 2026$36.5B+2.9%
Q4 2025$42.7B+1.7%
Q3 2025$37.2B+4.8%
Q2 2025$37.2B+1.8%
Q1 2025$35.5B+6.6%
Q4 2024$42B+7.6%
Q3 2024$35.5B+5.2%

BABA has the edge over HNST on sales, with more consistent year-over-year improvement.

HNST Quarterly Revenue

Q4 2023: $90MQ1 2024: $86MQ2 2024: $93MQ3 2024: $99MQ4 2024: $100MQ1 2025: $97MQ2 2025: $93MQ3 2025: $93MQ4 2025: $88MQ1 2026: $78MQ2 2026: $83MQ3 2026: $85M
Q4 2023: $90MQ1 2024: $86MQ2 2024: $93MQ3 2024: $99MQ4 2024: $100MQ1 2025: $97MQ2 2025: $93MQ3 2025: $93MQ4 2025: $88MQ1 2026: $78MQ2 2026: $83MQ3 2026: $85M
QuarterRevenueYoY
Q3 2026$84.6M-8.6%
Q2 2026$83.3M-11%
Q1 2026$78.1M-20%
Q4 2025$88M-12%
Q3 2025$92.6M-6.7%
Q2 2025$93.5M+0.4%
Q1 2025$97.3M+13%
Q4 2024$99.8M+11%

HNST's revenue has slid since its 2024 peak: $85M last quarter, down 8.6% from the same quarter a year ago.

BABA Free Cash Flow

Q3 2023: $5.4BQ4 2023: $11BQ1 2024: $34MQ2 2024: $3.2BQ3 2024: $2.1BQ4 2024: $10.4BQ1 2025: −$4.2BQ2 2025: −$2.7BQ3 2025: −$3.2BQ4 2025: $1BQ1 2026: −$2.7BQ2 2026: −$6.7B
Q3 2023: $5.4BQ4 2023: $11BQ1 2024: $34MQ2 2024: $3.2BQ3 2024: $2.1BQ4 2024: $10.4BQ1 2025: −$4.2BQ2 2025: −$2.7BQ3 2025: −$3.2BQ4 2025: $1BQ1 2026: −$2.7BQ2 2026: −$6.7B
QuarterFree cash flowYoY
Q2 2026-$6.7B-$4.1B
Q1 2026-$2.7B+$1.5B
Q4 2025$1B-90%
Q3 2025-$3.2B-254%
Q2 2025-$2.7B-182%
Q1 2025-$4.2B-12231%
Q4 2024$10.4B-4.8%
Q3 2024$2.1B-62%

BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.

HNST Free Cash Flow

Q4 2023: $10MQ1 2024: $260,000Q2 2024: $3MQ3 2024: $15MQ4 2024: −$17MQ1 2025: −$3MQ2 2025: −$826,000Q3 2025: −$624,000Q4 2025: $18MQ1 2026: $4MQ2 2026: $31MQ3 2026: −$5M
Q4 2023: $10MQ1 2024: $260,000Q2 2024: $3MQ3 2024: $15MQ4 2024: −$17MQ1 2025: −$3MQ2 2025: −$826,000Q3 2025: −$624,000Q4 2025: $18MQ1 2026: $4MQ2 2026: $31MQ3 2026: −$5M
QuarterFree cash flowYoY
Q3 2026-$4.8M-$4.1M
Q2 2026$31.5M+$32.3M
Q1 2026$3.8M+$6.8M
Q4 2025$18.1M+$35.2M
Q3 2025-$624K-104%
Q2 2025-$826K-128%
Q1 2025-$3M-1254%
Q4 2024-$17.2M-278%

HNST has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.

BABA Total Shares

Q3 2023: 2.6BQ4 2023: 2.5BQ1 2024: 2.5BQ2 2024: 2.4BQ3 2024: 2.4BQ4 2024: 2.4BQ1 2025: 2.4BQ2 2025: 2.4BQ3 2025: 2.4BQ4 2025: 2.4BQ1 2026: 2.4BQ2 2026: 2.4B
Q3 2023: 2.6BQ4 2023: 2.5BQ1 2024: 2.5BQ2 2024: 2.4BQ3 2024: 2.4BQ4 2024: 2.4BQ1 2025: 2.4BQ2 2025: 2.4BQ3 2025: 2.4BQ4 2025: 2.4BQ1 2026: 2.4BQ2 2026: 2.4B
PeriodChange %Net change
Quarterly+0.5%+11.1M shares
1 year+0.9%+21.4M shares
3 years-6.2%-161M shares
5 years-12%-339M shares
Available history-8.4%-221M shares

BABA has 2.4B diluted shares, up 0.9% from a year ago.

HNST Total Shares

Q4 2023: 95MQ1 2024: 96MQ2 2024: 99MQ3 2024: 105MQ4 2024: 100MQ1 2025: 115MQ2 2025: 114MQ3 2025: 114MQ4 2025: 111MQ1 2026: 113MQ2 2026: 113MQ3 2026: 112M
Q4 2023: 95MQ1 2024: 96MQ2 2024: 99MQ3 2024: 105MQ4 2024: 100MQ1 2025: 115MQ2 2025: 114MQ3 2025: 114MQ4 2025: 111MQ1 2026: 113MQ2 2026: 113MQ3 2026: 112M
PeriodChange %Net change
Quarterly-0.6%-627K shares
1 year-1.1%-1.2M shares
3 years+18%+17.3M shares
5 years+65%+44.4M shares
Available history+29%+25.3M shares

HNST has the edge over BABA on shareholder dilution, with a more favorable share count trend.

BABA Net Leverage

Q3 2023: -0.6xQ4 2023: -0.8xQ1 2024: -0.4xQ2 2024: -0.4xQ3 2024: -0.2xQ4 2024: 0.1xQ1 2025: 0.3xQ2 2025: 0.2xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.5xQ2 2026: 0.5x
Q3 2023: -0.6xQ4 2023: -0.8xQ1 2024: -0.4xQ2 2024: -0.4xQ3 2024: -0.2xQ4 2024: 0.1xQ1 2025: 0.3xQ2 2025: 0.2xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.5xQ2 2026: 0.5x
QuarterNet LeverageStatus
Q2 20260.5xVery low
Q1 20260.5xVery low
Q4 20250.6xVery low
Q3 20250.8xVery low
Q2 20250.2xVery low
Q1 20250.3xVery low
Q4 20240.1xVery low
Q3 2024-0.2xNet Cash

BABA's net debt is less than a year of its operating earnings (EBITDA).

HNST Net Leverage

Q1 2025: -218.7xQ2 2025: -9.9xQ3 2025: -9.4x
Q1 2025: -218.7xQ2 2025: -9.9xQ3 2025: -9.4x
QuarterNet LeverageStatus
Q3 2025-9.4xNet Cash
Q2 2025-9.9xNet Cash
Q1 2025-218.7xNet Cash

HNST has more cash than debt.

BABA Weekly Momentum

MetricValueStatus
RSI38.0Neutral
Stochastic12.7Oversold

BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).

HNST Weekly Momentum

MetricValueStatus
RSI54.0Neutral
Stochastic34.6Neutral

HNST's weekly RSI is 54 (neutral) and its Stochastic is 35 (neutral).

BABA PE vs Consumer Cyclical Sector

MetricBABASector medianRelative
PE21x18x19% above
PE %604713 pts above

BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.

HNST PE vs Consumer Cyclical Sector

MetricHNSTSector medianRelative
PE7x18x61% below
PE %35350 pts below

HNST has the edge over BABA on valuation relative to its sector.

BABA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$104.79.9% below
20 week MA$111.115% below
50 week MA$128.026% below
100 week MA$127.726% below
200 week MA$106.411% below

BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.

HNST Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.871.4% below
20 week MA$4.790.2% above
50 week MA$3.6930% above
100 week MA$4.1915% above
200 week MA$3.5436% above

HNST has the edge over BABA on trend strength, trading above more of its moving averages.

BABA Yearly ROI

YearStart priceEnd priceROI
2020$215.5$222.0+3%
2021$222.0$118.7-47%
2022$118.7$85.7-28%
2023$85.7$77.5-9.5%
2024$77.5$85.1+9.7%
2025$85.1$152.2+79%
2026 YTD$152.2$94.4-38%

BABA has finished lower in three of the last six years. It's down 38% so far in 2026.

HNST Yearly ROI

YearStart priceEnd priceROI
2021$19.1$8.07-58%
2022$8.07$2.97-63%
2023$2.97$3.30+11%
2024$3.30$6.93+110%
2025$6.93$2.71-61%
2026 YTD$2.71$4.80+77%

HNST has the edge over BABA on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key